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Summary Nitric oxide (NO). an endogenous free radical, has been implicated in a wide range of biological functions. NO is generated
enzymatically from the terminal guanidinonitrogen of L-arginine by nitric oxide synthase (NOS). Despite intensive investigations, the role of
NO - either as the primary product of the L-arginine/NOS pathway or provided from the NO donor sodium nitroprusside (SNP) - in
carcinogenesis and tumour cell growth remains unclear and controversial. The objective ofthis study was to examine the growth effects of NO
on a ductal pancreatic adenocarcinoma in the rat and on a human pancreatic tumour cell line (HA-hpc2). In vivo, both SNP and endogenous
induction of NO by endotoxins [lipopolysaccharide (LPS)] plus L-arginine significantly reduced the tumour growth. To investigate the
mechanisms of NO anti-tumour growth action. the effects of either the SNP or L-arginine/NOS pathway were analysed on the HA-hpc2 cell
line. Nitrite/nitrate production, NOS activity and iNOS expression [assessed by reverse transcription-polymerase chain reaction (RT-PCR)]
were tested and related to growth (assessed by [3Hjthymidine incorporation assay) and apoptosis (assessed by intemucleosomal DNA
cleavage). SNP exerted a dual effect on tumour cells: stimulation of the proliferation up to 1 mm and inhibition at higher concentrations. These
effects were related to NO production. Both proliferative and cytostatic responses were inhibited by NO scavenger 2-phenyl-4,4,5,5-
tetramethyl-hemidazoline-l-oxyl3-oxide (carboxy-PTIO). The marked apoptotic DNA fragmentation induced by SNP was also abolished by
PTIO association. Unlike macrophages, the human pancreatic tumour cells did not seem to express intrinsicalty the L-arginine/NOS pathway.
Macrophages were activated by HA-hpc2 cells as well as by LPS plus cytokines [interleukin (IL)-15 plus tumour necrosis factor (TNF)-ca and
interferon (IFN)-y,. In HA-hpc/macrophage co-cultures. NOS activity and inducible NOS (iNOS) transcription were stimulated, whereas an
antiproliferative response was observed. These effects were related to both macrophage amount and NO production. Addition of LPS plus
cytokines to co-cultures doubled iNOS activity, nitrite/nitrate production and tumoricidal effect. These data suggest the involvement of NO in
pancreatic tumour growth and support the fact that generation of high levels of NO with potential production of endogenous reactive nitrogen
intermediates may contribute to induction of apoptosis and tumour growth inhibition.
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Nitric oxide (NO). first identified as an endothelium-derix ed
relaxing factor (Palmer et al. 1987). emerges as a strikino signal
transduction molecule MN-olxed in a large xariety of pathophxsio-
logical processes (Moncada et al. 1991). NO is generated as a free
radical through a NO sxnthase-mediated oxidation (requiring addi-
tional NADPH (Gabott and Bacon. 1993) ofthe terminal cuanidine
nitrogen of L-arginine. As demonstrated bx molecular cloning
(Lams et al. 1992: Xie et al. 19921. there are at least txo NO
svnthase isoform classes: a constitutixve (cNOS) or Ca'--calmod-
ulin-dependent one and an inducible (iNOS) or Ca'-independent
one. even though this class has been shown to have a calmodulin
binding site (Bredt and Snxder. 1990: Moncada et al. 1991: Cho et
al. 1992). Prexalent in some cell txpes such as endothelial (eNOSI
or neuron (nNOS) cells. cNOS isoforms are activated xia intracel-
lular Ca' increase or physical stimulus. Requiring, calmodulin but
not Ca'- increase for its acti'itx.iNOS generates negligible NO
under basal conditions. Inducible in macrophages. hepatocytes.
endothelial or Xascular smooth muscle cells. its transcription
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requires cytokine [interferon (IFN -y. tumour necrosis factor
(TNF>-Ct and interleukin (IL(-I13] and/or endotoxin actixvation
(Hibbs et al. 1987: Stuehr and Marletta. 1987: Lepoix-re et al. 1989).
It has been long recognized that actix ated macrophages produce
cvtotoxic or at least cytostatic effects on microbial pathogens and
tumour cells (Weinberg et al. 1978). Xia a release ofboth cvtokines
and NO (Palmer et al. 1987: Kuwon et al. 1990: Hibbs. 1991). In
addition. bacterial lipopolxsaccharide (LPS) or cytokine iNOS
activation induces macrophage NO sx nthesis (Stuehr and
Marletta. 1987). Acting as a powerful reducinc and oxidizing
agyent able to donate and catch electrons (Beckman et al. 1990 .
NO can interfere with iron-sulphur-containing enzymes ensuinLg
iron release and inhibit both mitochondrial electron transport chain
(Stuehr and Nathan. 19891 and ribonucleotide reductase actixitv
(Lepoix-re et al. 1990). a rate-limitina step in DNA sxnthesis. As a
matter of fact. the potential consequence of producing large
amounts of NO mav be local cxtotoxicitx. As a radical. NO reacts
with oxvLgen species and w-ater. formincg other tissue toxic N-
oxides such as peroxynitrite (Beckman et al. 1990: Esumi and
Tannenbaum. 19941. The role of NO and its closel1 related cata-
bolic products such as NO-/NO- in the pathogyenesis of inflam-
mation and tumour cell death or apoptosis (Nguxen et al. 1992:
Esumi and Tannenbaum. 1994 can be explained this waxy.
Excessixe NOS induction. leading to too large a quantitx of NO
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production. has also been implicated in endothelial cell damage
(Beckman et al. 1990). Accumulation of all these highly reactive
compounds (NO radical. nitrite. nitrate. peroxynitrite and peroxy-
nitrate) suggests potential genotoxic effects of NO in target cells
(Nguyen et al. 1992).
We have designed the present study to evaluate both the effect
ofpancreatic tumour cell growth inhibition by NO overproduction
and the possible role of macrophage-derived NO in mediating
tumoricidal activity in vivo and in vitro.
MATERIALS AND METHODS
Media and ragents
NG-nitro L-arginine methyl ester (L-NAME). L-arginine and >-
arginine hydrochlorides, sulphanilamide. N-(naphthyl)ethylene-
diamine dihydrochloride. FAD, lipopolysaccharide (LPS).
NADPH. nitrate reductase. sodium nitroprusside (SNP). sodium
nitrate, sulphalinic acid, Dowex AG50 W-X8, aprotinin. leupeptin
and carboxy-PTIO were purchased from Sigma-France. DMEM,
RPMI, Hanks' balanced salt, fetal calf serum and antibiotics
were provided from Gibco BRL (Cergy-Pontoise, France).
Recombinant TNF-a, IFN-y and EL-l[ were obtained from
Euromedex (Strasbourg, France), [3H]thymidine (specific activity
of S Ci mmol-') and L-[2,3,4,5-3H] arginine (specific activity of
68 Ci mmol-') from Amersham (Les Ulis, France). MoMLV.
reverse transcriptase and Taq polymerase were purchased from
Appligene (Strasbourg. France) and iNOS oligonucleotide primers
from Eurogentec (Angers. France).
In vivo experiments
Experimentalanimals
Male Lewis rats (180-200g) and male C3H/HeN mice (6-10
weeks old) purchased from Charles River Laboratories (Orleans.
France) were maintained according to the guidelines forlaboratory
animal use and care with free access to tap water and standard
specific chow.
Tumoursystem
The rat ductal pancreatic carcinoma is derived from a primary
transplantable acinar carcinoma that was originally chemically
induced by azaserine in Lewis rats (Pettengill et al, 1993). Tumour
cell preparation has been described previously (Hajri et al, 1992).
Briefly, tumour tissue from the donor rat was removed, washed in
ice-cold Hank's balanced salt, sliced, passed through a no. 30
stainless-steel screen and centrifuged (500g). For tumour injec-
tion, the pellet was resuspended (v/v) in DMEM before cell count.
Aliquots ofapproximately 150 jil ofthe final suspension ofalmost
5x106 cells were injected during laparotomy at a single site into
the pancreas of 24 ketamin anaesthetized rats, as described else-
where (Hajri et al, 1992). Ten days later(a time interval fortumour
to attain a volume of0.3-0.5 cm3) rats were randomly allocated to
four experimental groups ofeight animals.
Experimental schedules
Animals were injected daily i.p. for 15 days with either 500gi of
sodium chloride solution (9 g 1-1) or 100 mg kg-' sodium nitro-
prusside, or 400 mg kg-' L-arginine monohydrochloride alone or
added to 50 mg kg-' L-NAME. The last two groups also received a
3 mg kg-' endotoxin (LPS) i.p. injection at 5-day intervals. After
euthanasia using an injectable agent (ketamine i.p.). tumours were
removed. weighed and measured with a calliper. Pancreatic
tumour contents in protein. RNA and DNA were determined
according to the methods ofLowry et al (1951). Schneider (1957)
and Richards (1974) respectively.
In vitro experiments
Cell cultures andexperimentalprocedures
The human pancreatic tumour cell line and the murine peritoneal
macrophages wereroutinely cultured in DMEM or RPMI medium
supplemented with 2 mM L-glutamine. 100 U ml-' penicillin.
100 jg ml' streptomycin and 10% fetal calf serum. The cell
cultures were maintained at 37°C in a humidified incubator
containing 5% carbon dioxide in air.
Harvested in ice-cooled PBS plus 25 ffm glucose from
C3H/HeN mice treated 48 h before with 1.5 ml of 10% thioglycol-
late broth. macrophages were pelleted at 4°C. washed twice and
counted. Then. 5x1O5 macrophages perml ofmedium were seeded
in plastic dishes (1 ml per well) and plated for initial cell cultures.
After a 2-hincubation, non-adherent cells were removed by exten-
sive PBS washing and remaining adherent macrophages were
cultured in fresh medium for24 h. Then, the medium waschanged
and 5 mM L-arginine monochloride and specific NO inducers
(10 jg ml-' LPS. lOng ml-'IIL-1 plus 20ng ml'- IFN-y and
20 ng ml TNF-a) were added, alone or in combination, for 24 h
with or without NO inhibitor (5 MM L-NAME).
An onginal pancreatic tumour cell line (called HA-hpc,) was
used as tumour target cells. This cell line. derived from metastatic
liver tumour of a human pancreatic adenocarcinoma. was estab-
lished in ourlaboratory in tissue culture and in nude mouse (with a
preserved carcinogenicity). This cell line produced ductal tumour
markers such as mucine plus carbohydrate antigen 19-9 and did
not express acinar cell markers such as amylase (unpublished
data). In these experiments. HA-hpc, cells were cultured in a
DMEM medium (SxlIO cells ml-') supplemented as described
above for 24 h. Then. the medium was changed and specific NO
donor(SNP, from 0 to 10 mM) was added for 24 h with or without
carboxy-PIO (10-7 and 10- M) as NO scavenger, or5 mM L-argi-
nine monochloride and specific NO inducers were added for 24 h
(10 jig mll LPS. with or without 10 ng ml-' IL-15plus 20 ng ml'
IFN-yand 20 ng ml-' TNF-a). with or without NO inhibitor(5 mm
L-NAME).
Co-culture of macrophages with pancreatic tumour cells was
also performed. At the time of macrophage monolayer medium
renewal, cells were harvested. counted and an increasing amount
(106, 10. 5xlO and 106 cells) was mixed in 24-well plates with
tumour cells (initially 106 cells) growing for 24 h in 1 ml of
DMEM medium. These co-cultures were supplemented in 5 mM L-
arginine alone or with NO inducers (10 jg ml' LPS. with or
without 10 ng ml' IL-1p plus 20 ng ml-' IFN-y and 20 ng ml-'
TNF-a), with or without the NO inhibitor (5 mM L-NAME) and
incubated in a humidified 5% carbon dioxide incubator for 24 h.
Assay ofnitrate/nitnte
NO release was appraised by the determination of accumulating
oxidation products in cell culture supematant. Nitrite concentra-
tions in phenol red-free medium were measured by the colori-
metric Griess reaction (Hageman and Reed. 1980) after reducing
nitrates to nitntes using nitrate reductase in presence of FAD
(5 jiM) and NADPH (50 jm). After nitrate had been reduced to
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Figure 1 Effects of increasing sodium nitroprusside concentrations on
human pancreatic ductal tumour cell [3Hjthymidine incorporation (_) and
nitrite/nitrate release in cell culture medium (0) 24 h after supply. Results are
the means (± s.e.) of six experiments. The dose-correlated exponential or
logarithmic curves were processed by Cricket Graph 2.1 software. All
changes are significantly different (P<0.O01) from control values (no sodium
nitroprusside). except for [HJthymidine incorporation achieved with 0.1 mm
sodium nitroprusside
nitrite, excess of NADPH. x-hich interfered with the subsequent
nitrite determination. was oxidized with L-lactic dehvdrogenase
and sodium pyru'vate. The Griess reagent w as prepared by mixing
equal xolumes of sulphanilamide (1c in 2.5%7 phosphoric acid)
and N-m naphthN ethy lene-diamine dihvdrochloride (O.1'7 in
2.5%;- phosphoric acid). Sample aliquots of 100 p1 (diluted if
needed) were transferred to 96-well microassay plates and incu-
bated for 10 min at room temperature in the dark. after addition of
an equal volume of Griess reagent. Absorbance of the chromo-
phore formed was measured at 540 nm and nitrite was quantified
bx usin2 sodium nitrite as a standard. Nitrite concentration w-as
expressed in nmol ml-l
Extraction and measurement ofnitric oxide synthase
activity
Cells were washed w-ith PBS. scraped and suspended in a l-sis
buffer [40 imn\ HEPES. pH 7.4. 32 mn- sucrose. 1 m.s DTT.
2 [lg ml-' aprotinin. 10 ji, ml-I leupeptin and 10 jgc ml-' soybean
trypsin inhibitor (SBTI)]. Cell Iysis xxas achiexed by freeze thawx:
the suspension was centrifuged at 10 000g for 30 min at 4 C. A
Doowex-AG 50 WA-X8 (Na- form) column (prepared from the H-
form resin bv I sodium hydroxide and purified w-ater w-ashing
until pH reached almost 6) w-as used to remo\e endogenous argi-
nine from the cell l-sate. NOS acti'vity x-as then assayed by
measuring the enz-matic conversion of [`H]L-arginine to ['H]L-
citrulline (Laskin et al. 1995) in the cell extract eluates. A sample
of cell extract eluate (40 PI) w-as incubated for 45 min at 37-C in
presence of a reaction buffer (40 m-i Tris/HCI. pH 8.0. 0.2 mnst
NADPH. 4 jis\ fla\-ine adenine dinucleotide. 6 ni\t valine as
arcinase inhibitor. 0.2 mv\t calcium chloride. 3 mist DTT. 10 mM\ L-
arginine and 3.5 jM L-[2.3.4.5-`H]ar2inine. The reaction xxas
stopped in ice and 500 p1 of a water/Dowex-AG 50 W-X8 mixture
('-olxol) was added. The resin w-as washed twice w-ith 1 ml of
purified water. and 1 ml of supernatant was used for radioactix its
determination by scintillation counting in presence of 2 ml of
Figure 2 Reverse-phase microscopic aspects of HA-hpc2 pancreatic
tumour cells after a 48-h culture with 0.5 (A) or 2.5 mm (B) sodium
nitroprusside 24-h treatmnent. The 0.5 mm sodium nitroprusside-treated
culture had the typical cobblestone appearance of pancreatic duct cells in
culture. The 2.5 mm sodium nitroprusside treatment produced obvious
changes in cell number and aspect with some pyknotic figures (actual
magnification x 10)
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Figure 3 Effects of the NO scavenger carboxy-PTIO on [3HJthymidine
incorporation in DNA of HA-hpcW tumour cells treated with increasing sodium
nitroprusside concentrations. Sodium nitroprusside alone, *: 10- M carboxy-
PT1O,-: 1 m carboxy-PTIO. I. Results are mean (+ s.e.) of six
experiments. Statistcal comparisons were done towards untreated cells.
...PF0.001
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Pico-Fluor liquid. Nitric oxide synthase activitv was expressed in
pmol min-''g ofprotein.
PH]thymidine incorporation assay
Tumour cell proliferation after each kind of treatment was assessed
after 1 daN, ofculture by determining the [ H]thyridine incorporation
into DNA. Briefly. 0.5 iCi ml - of [methWl-`H]thmi`1dine was added
and cells were incubated for 24 h. After PBS washino. cells w-ere
incubated for 20 mn in ice-cold 10%7 TCA. rinsed and lsed bN-
adding 750 jl per well of sodium hvdroxide 0.4 N for 30 min at
37-C. The amount ofradioactivity incorporated in DNA per well Aas
determined by liquid scintillation spectrometrs of the cell lINsate.
[H]Thymnidine incorporation was expressed in c.p.m. per well.
Electrophoretic detection ofintemucleosomal DNA
cleavage
After each specific treatment. tumour cells sere pelleted at 4-C.
resuspended in a lysis buffer (0.2 m TrisfHCl pH 8.0. 20 nm\
EDTA. 100 lga ml-' proteinase K and 10 .gs ml-' SDS) and incu-
bated for 4 h at 37^C. After RNAase treatment 1100 tgc ml- for
I h at 37-C. DNA was extracted wxith a phenol-chloroform
mixture (vol/vol) and precipitated w-ith sodium acetate 3 si
( 1/10 Xolb and ice-cold ethanol (2.5 s-ol) for I h at room tempera-
ture. DNA samples and a 100-bp DNA ladder (Promega.
Charbonnieres. France) were mixed with loading buffer (30C%
alx-cerol. 0.1%c bromophenol blue) and loaded onto 1.8%c agarose
gels and electrophoresed for approximately I h at 50 V. The gels
were stained w-ith ethidium bromide. and the DNA bands were
visualized under 312-nm light.
RT-PCR ofinducible NO synthase mRNA
Sinale-strand cDNA v-as reverse transcribed from total RNA.
extracted bv the cuanidinium isothiocyanate method
(Chomczx nski and Sacchi. 19871. using Molonex murine
leukaemia virus (MoMLV) reverse transcriptase (RT) and (dT) -
primer or random hexamers. Reverse transcription wxas carried out
Table 1 Endogenous nrtic oxide induction and effects on macrophage and pancreatic tumour cell growth
Nitrite/nitrate (nmol per well) [3H]Thymidine (c.p.m. per well)
No L-NAME + L-NAME NO L-NAME + L-NAME
Murine macrophages
L-Arginine 2.6 1.0 106:: 10
L-Arg/LPS 30.2 1.3a 23.1 -09- 102 12 91 10
L-Arg/LPS + cytokines 44.2:t 1.4a 37.0 _15a- 108 16 113 17
Human pancreatic tumour cells
L-Arginine 1.8 0.4 4838- 366
L-Arg/LPS 2.2 +0.4 1.4 _0.2 3400
- 241 3821 -153r
L-Arg/LPS + cytokines 3.1 t 0.4 1753: 125a
Values represent the means (::s.e.) of six experiments. Each well contains 5 x 10- cells in 1 ml of medium. Cytokines (IL-1i . IFN-y and TNF-a) were added to
L-arg/LPS treatment (L-arginine and LPS stimulation). The NOS inhibitor (L-NAME) was tested on L-arg/LPS experiments. Statistical comparisons were done
towards L-arginine control values (-p < 0.001. P < 0.01) and. when L-NAME treatment was applied. towards the corresponding L-arg/LPS group ( P < 0 01).
Table 2 Effects of increasing concentration of macrophages on human pancreatic tumour cell growth
106 tumour cells Nitrite/nitrate (nmol per well) [3lHThymidine (c.p.m. per well)
in addition to
No L-NAME + L-NAME No L-NAME + L-NAMIE
No macrophage
+ L-Arginine 3.0t 1.0 2.8 0.8 10295- 304 10561 - 333
+ LPS + cytokines 5.6 - 1.1 4.1 1.9 4939 - 3.8C 6945:r:297c
10 macrophages
+ L-Arginine 3.1 0.9 2.1 -0.6 10627 -293 10968- 368
+ LPS + cytokines 5.5 1.4 4.1 2.1 5298- 296: 7708 -517-
1 Q5 macrophages
+ L-Arginine 8.9: 1.3 4.1 t 0.7- 8252 283 9505 - 511
+ LPS + cytokines 29.2 - 5.7- 12.6 1.7 3637 z 222c 5655 + 462c
5 x 10(Y macrophages
+ L-Arginine 341 +2.2 24.1 -16- 5393 - 180 6329- 484
+ LPS + cytokines 61 5 t28- 43.3 -39 1962 t 192c 3555 -427T
1oe macrophages
+ L-Arginine 51.9 3.3 37 1 _ 2.8 2785 = 225 3887
- 443
+ LPS + cytokines 91.2 t5.5c 65.2t 42a 807 - 106c 1738 - 357a
Values represent the means (_ s.e.) of six experiments. Co-cultures supplemented in L-arginine alone served as controls. Both LPS and cytokines (IL-1i. IFN-;i
and TNF-a) were added to co-culture medium. All the experiments were performed with and without the NOS inhibitor (L-NAME). For each macrophage
concentration. statistical comparisons were done towards the corresponding L-arginine-no L-NAME control values (ap< 0.05. :P< 001.-P < 0.001).
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Figure 4 Computed correlation between nitrite/nitrate and [3H]thymidine
incorporation mean values in macrophage-human ductal tumour cell co-
cultures. after 24-h L-arginine treatment (5 mm). without ( -) or with 5 mu L-
NAME (0). after LPS (10 ug mV-) and IL-153 (10 ng mh1). IFN-y (20 ng mh')
plus TNF-a (20 ng mt-) without ( ) or with L-NAME (A). Computed by
Cricket Graph 2.1 software. the exponential correlation curves were similar
with each kind of treatment and are superimposed in a graph with
semilogarithmic y-axis
in a 20-uil total x-olume reaction w-ith a final concentration of
40 ng ml-' random hexamer as primer. 5 mm DTT. 1 mm dNTP.
0.8 U ul-' RNAase. 5x buffer (0.25 xm Tris-HCl. pH 8.3. 0.375 mM
potassium chloride. 15 mm magnesium chloride). 1-5 ig- of total
RNA and 200 U of MoMLV. The reaction mixture w-as incubated
for 1 h at 37 C. Thereafter. RT w-as denatured by heating for 10
min at 94^C and chilled in ice. In some tubes RT was omitted for
contaminating cDNA or genomic DNA amplification control. The
cDNA was stored at -0^C. The iNOS oligonucleotide primers
(Eurogentec. Angers. France) iN1 (5'-GTGAGGATCAAA-
AACTGGGG-3') and iN2 (5'-ACCTGCAGGTTGGACCAC-3').
corresponding to a homologous sequence in human and murine
2ene. xwere used to amplify an appropriate 380-bp fragment.
Glyceraldehvde-3-phosphate dehydrogenase (GAPDH) primers
(Clontech. Montignr -le-Bretonneaux. France) were used as an
internal control. The polxmerase chain reaction w-as performed
using 5 ul of each RT reaction. 0.8 mis of each of the sense and
antisense primers. 0.8 mist ofdNTP. 2 mm magnesium chlonrde and
2 U of Taq DNA pol-merase per reaction (final Xolume 50 p1). For
amplification each PCR mixture was subjected to 35 cycles of
denaturinn 45 s at 94 C. annealinc 45 s at 60^C and extension
2 min at 72'C. Equal amounts of PCR products (iNOS and
GAPDH were analvsed on 2' agarose gels containin2 ethidium
bromide.
Statistical analysis
.Mean and standard error of the mean w-ere calculated. Statisticallx
sienificant difference betxween treatments was assessed using a
one-wxav anal-sis x-anance (ANOVA followxed by a parametric
Student unpaired t-test. where Bartlett's test gaxe homogeneity of
xariance. or by a non-parametric Mann-Whitney test for signifi-
cantly different xvariances. Difference was considered sicgnificant
when P<0.05. Statisticallx sianificant difference towards 0 was
assessed in the same way by a one-group comparison with a
Student t-test. Correlation betwxeen some parameters wxas studied
Figure 5 Agarose gel electrophoresis of DNA from treated HA-HPC2
(human pancreatic carcinoma cell line) cells. The DNA was harvested from
cells that were untreated (lane 1). treated for 24 h with 0.1 (lane 2). 0.5 (lane
3). 1 (lane 4). 2.5 (lane 5) and 5 mm (lane 6) of SNP. or a combination of 5 mm
L-arginine. 10 ug mt- LSP. 10 ng mr- IL-13 and 20 ng mrn TNF-a (lane 7).
The characteristic pattem of intemucleosomal DNA cJeavage (DNA ladder).
indicative of endonuclease activation. can be seen in lanes 4-6. Molecular
weight is the 100-bp DNA ladder. Similar results were obtained in five other
identical experiments
using a parametric Pearson test or a non-parametric Spearman test
w-hen xariances were significantlI different. Instat 2.00 Macintosh
software (GraphPad Softxare. San Diego. CA. USA) >-as used.
Correlation curves were computed usinc Cricket Graph 1.2 soft-
w-are (Cricket Software. Malvern. PA. USA).
RESULTS
Modulation of pancreatic tumour growth in vivo by
exogenous and endogenous NO
The most obvious chanae induced bv SNP and LPS treatments was
seen in tumour Xolumes (almost three times smaller than 'control )
and related to tumour masses (data not show-n). The other grow-th
parameters. expressed per g of wxet w-eight. w-ere slightly (almost
20c% decrease in protein and 30%c decrease in RNA contents) or
not sigmificantlv affected (no chanae in DNA content). The
addition of L-NANME did not suppress the inhibitorx effects of
L-arginine and LPS (data not show-nI.
Exogenous NO effects on pancreatic tumour cell
growth in vitro
As illustrated in Figure 1. increasing concentrations of SNP eave a
dose-related release in nitnrte/nitrate (correlation coefficient r =
0.931. follow-ing an increasing logan'thmic pattern. The data of
['H]thy-midine incorporation in tumour cell DNA (Fig-ure 1) also
show-ed a dose-related exponential rise (r = 1) up to a 0.5 nmi SNP.
There is a strona correlation (r = 0.961 betvx-een SNP-induced NO
lexels and ['H]thNmidine incorporation rates. At hiaher concentra-
tions of SNP (1-10 mmsi. the ['H]thymidine incorporation
decreased in a dose-related manner (r = -0.971 according to a loga-
rithmic pattern. There is an inverse relation (r = -0.851 betxween
NO production and [ H]th\ midine incorporation.
These data A-ere corroborated b\- the results of tumour cell
culture obserxations by reverse-phase microscopy (Figure 21 after
a 24 h-treatment xxith either 0.5 mn\ (Fiaure 2A) or 2.5 m.i- SNP
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Figure 2B). The typical tight confluent cobblestone appearance of
pancreatic tumour cells in culture wvas still present in 0.5 rnm
pretreated HA-hpc, cells (Figure 2A). In 2.5 mm pretreated cells
(Figure 2b) cell confluence was not achieved and many floating
cell clusters. sign of a cytotoxic effect. %vere obsen-ed.
The cytostatic effect of SNP concentrations higher than 1 mm
was not linked to a deleterious action of some breakdown products
ofSNP. The addition ofthe NO scavengercarboxy-PIlO inhibited
the whole decrease in [FH]thymidine incorporation achieved with
both 1.5 and 2.5 mm SNP (Figure 3). The positive effect of SNP
concentrations lower than 1 mm on proliferation of HA-hpc, cells
was also inhibited by the addition of the NO scavenger carboxv-
PTIO (Figure 3).
Endogenous NO induction and effects on macrophages
in culture
The effects of NO-inducing agents (LPS plus L-arginine and
cvtokines) and of the NOS inhibitor (L-NAME) on macrophages
are summanzed in Table 1. As expected. LPS plus L-arginine dras-
ticallI increased NO release to the cell culture medium (more than
13-fold). This NO production Was L-arginine dependent. as the use
ofE-arginine at the same concentration failed to generate NO (data
not shown). The addition of cvtokines (IL-15. IFN-y and TNF-a)
increased the release of NO bv 45%7c (P<0.001). The addition
of L-NAME reduced these releases of NO slightl (almost 20%.
P<0.01). No significant change was observed in ['H]thvmidine
incorporation in cellular DNA whatever treatment w-as applied to
the macrophages.
Endogenous NO induction and effects on tumour cells
in culture
The tumour cell effects of NO-inducinr agents (L-arginine/LPS
and cvtokines) and of the NOS inhibitor (L-NAME) are summa-
rized in Table 1. Nitrite/nitrate release from control tumour cells
w-as slightlv but significantIs lox er than from control
macrophages: 1.8 ± 0.4 vs 2.6 ± 1.0 nmol per well (P<0.05).
suggestin, low-er tumour cell cNOS actiVitV. L-Arrinine/LPS stim-
ulation did not sionificantlv affect NO release from HA-hpc, cells.
unlike the 13-fold increase achieved in the macrophage cell
culture medium. suggesting an almost negligible iNOS activity.
The addition of L-NAME to L-arginine/LPS treatment affected
slirhtly but not significantly ['H]thymidine incorporation or
nitrite/nitrate production. Cvtokine addition increased slightly
nitrite/nitrate level and reduced the rate of [ H]thy midine incorpo-
ration by 50%.
Figure 6 Agarose gel electophoresis of DNA from SNP-treated HA-HPCI
cells. The DNA was harvested from cells that were untreated (lane 1). treated
with 1.5 mm SNP alone (lane 2) and in combination with 10 e M (lane 3) or
1 0-7 M(lane 4) of the NO scavenger carboxy-PTIO. 2.5 mm of SNP alone
(lane 5) and in combinaton with 10-4 M (lane 6). or 10-- M carboxy-PTIO (lane
7). The characterstic pattem of intemucleosomal DNA cleavage (DNA
ladder). indicative of endonuclease activation, can be seen in lanes 2 and 5.
Similar results were obtained in five other identical experiments
Macrophage involvement in tumour cell growth
changes
The effects of macrophages on NO release in co-culture medium
and on ['H]thvmidine incorporation are summarized in Table 2.
According to our obser-vations (Table 1). the concomitant addition
of L-arginine plus LPS and cytokines to tu-ice the number of
tumour cells did not affect NO release sirnificantly when
macrophages w-ere missing but reduced tumour cell proliferation
by 50%. L-NAME supply decreased partlv (almost 25%e) this
effect. No significant change >-as induced by addition of 104
macrophages ml-l (macrophage-tumour cell ratio 1:100). From
Ia (ratio 1:10) to I0U(ratio 1:I )macrophagres per ml an increasing
NO release and a concomitant decrease in [LH]thymidine incorpo-
ration were found. There is a strong correlation (r = -0.96)
betxeen the amounts of nitrite/nitrate released and the rates of
[`H]thymidine incorporation inhibition. following the same expo-
nential correlation curve (Figure 4) whatex-er co-culture treatment
was applied.
It is noteworthy that tumour cells alone were able to activate
macrophages drastically. In fact. for an identical stimulation
(L-arglnine alone or LPS plus cytokines) NO release from
macrophages in monocultures (Table 1) was significantly low-er
(P<0.001) than in co-cultures u-ith tumour cells (Table 2. 5x105
macrophages).
Table 3 Nitric oxide synthase activity changes induced in human pancreatic tumour cells. macrophages and macrophage-tumour cell co-cultures
HA-hpC2 Macrophages HA-hpc/nacrophages
Number of clls 5 x 10 5 x 1O0 5 x 11055 x 105
L-Arginine ND 7+3 214+29c
L-Arg/LPS ND 41 t 7a 298 + 15-
L-Arg/LPS + cytokines ND 125 -11t 435 + 31:-
Values. expressed in pmol mirn- gt of proteins. represent the means (+ s.e.) of six experiments. ND. not detectable. Cytokines (IL-1 3. IFN-y and TNF-a) were
added to L-arginine plus LPS (L-arg/LPS) treatment. Statistcal comparisons were done towards L-arginine values (aP < 0.01. FP < 0.001) and between
macrophages cultures and AH-hpcjmacrophages co-cultures (cP < 0.001).
British Joumal ofCancer (1998) 78(7). 841-849 0 Cancer Research Campaign 1998Nitric oxide andpancreatic tumourgrowth 847
In macrophage-tumour cell co-cultures. basic enzyme actixity
was dramatically enhanced (30 times higher than in macrophage
cultures). Further increases in NOS activity xvere induced bv LPS
(+40%) and by LPS plus cytokine additions (+100%lc).
Inducible NO synthase gene transcription
Figure 7 shows the RT-PCR amplification of NO synthase mRNA
in pancreatic tumour cells. macrophages and macrophage-tumour
cell co-cultures. Almost undetectable in tumour cell (lane 1). ex en
after LPS/cxtokine activation (lane 3). its expression in
macrophages was easily detectable (lane 2). improved bv
LPS/cytokine activation (lane 4). In macrophage-tumour cell co-
cultures the level of iNVOS gene transcripts increased dramaticallx
(lane 5).
Figure 7 Agarose gel electrophoresis of RT-PCR products for iNOS mRNA
(380 bp) and for GAPDH mRNA (452 bp) after ethidium bromide staining.
Lane 1, untreated human pancreatic tumour cells; lane 2. untreated mice
peritoneal macrophages; lane 3, a 24-h treatment of 5 x 1OY tumour cells with
LPS (10 pg ml-) and cytokines (IL-15. 10 pg ml- and TNF-c. 20 pg ml-)
had no effect; lane 4. a 24-h treatment of 5 x 1OY macrophages with LPS
(10 ug ml-) and cytokines lL-1P 10 ng ml-! and TNF-at. 20 ng mV-)
enhanced iNOS mRNA levels; lane 5, untreated 5 x 0l macrophage co-
culture with 5 x 101 tumour cells strongly enhanced iNOS mRNA levels. PCR
products for the GAPDH gene were taken as the reference cellular transcnpt.
Molecular weight is the 100-bp DNA ladder. Similar results were obtained in
five other identical experiments
L-NAME reversed only- part of the antiproliferatixe effects of
unstimulated (+15%7c increase in [H]thx midine incorporation
xwith I0W macrophages up to +33%7 with 10¼) and stimulated
macrophages (+55%c increase in [ H]thymidine incorporation wxith
lW macrophages up to +90%7 with 10). In the same way. NO
release Awas not abolished but onlI reduced (--60%7c with IQ5
macrophages down to -30'%c wxith 10¼).
Intemucleosomal DNA cleavage by NO release in
pancreatic ductal tumour cells
Figure 5 (lanes 4-6) shows the typical DNA ladder fragmentation
pattem in agreement with cell apopotosis. This pattem was
detected w-hen tumour cells were incubated 24 h in the presence of
1.5. 2.5 and 5 m-i of SNP. This degradation pattem was not
observed when 24-h incubation was carried out with 0.5 mmol (or
less) ofSNP (lanes 2 and 3). This pattern as also absent when the
NO scavenger carboxv-WO was added to 1.5 mMf (Figure 6.
lanes 3 and 4) or 2.5 mn of SNP (Fiaure 6. lanes 6 and 7). DNA
ladder fragmentation pattem did not appear when the pancreatic
tumour cells were treated with a combination of L-arginlne. LPS
and cytokines (Figure 5. lane 7).
Nitric oxide synthase activities
The lexvels of NOS actixitx in tumour cell cultures. macrophage
cell cultures and tumour cell-macrophage co-cultures are summa-
rized in Table 3. In tumour cells. NOS activitx alwavs remained
undetectable. exen after incubation with LPS and cvtokines. In
macrophages. the inherent enzyme activityx as increased (almost
six times) bv the addition of LPS. The cxtokine treatment
increased NOS actixvity oxer twofold.
DISCUSSION
The pharmacological studies relating to the role of NO in medi-
ating carcinogenesis and tumour growth haxe y-ielded controxer-
sial results with regard to the kind of cancers and the design ofthe
investioations (Hibbs. 1991: Taniouchi et al. 1993: Esumi and
Tannenbaum. 1994). In the present study wAe describe our attempt
to evaluate the effect ofhigh level ofNO and oflocal NOS produc-
tion on pancreatic tumour growth.
Chemically derixed NO (from SNP) inhibited significantly the
growth of allografted pancreatic tumour cells. This effect may be
attributed to NO and its derixatixes produced in the peritoneal
cavitv. Nitrite/nitrate concentrations w-ere increased in blood and
urine (data not shown). The i.p. injection of LPS beside L-arginine
showed a similarly potent inhibitorv effect on the growth of allo-
grafted pancreatic tumour cells. The endotoxin dosage used in our
experiment was low-er than the one (5 mg, per kg) inducincy
multiple organ failures in rats (Laskin et al. 1995). Peritoneal
macrophages in tumour vicinity and more especiallv those infil-
tratincg pancreatic tumour xx-ere activated. It is known that the
bacterial membrane LPS induces the production of some host
inflammatory mediators such as TNF-x. IL-l1 and IFN-y. which
in tum causes an increase in iNOS expression. With both SNP and
LPS. all growth parameters expressed per of tumour were
reduced. except DNA content. This may reflect an early reduced
tumour grow-th linked to either a primarx tumoricidal response.
ensuingy the selection of resistant clones. or to a defect in Xascular
supply by the release of antiangiogenic factors. This mav also
reflect that tumour cells were undergoing apoptosis. The effect of
LPS w as not rexersed by the chronic L-NAME treatment. The dose
of NOS inhibitor used mav be too low. and consequently L-ar2i-
nine masked L-NAME effect. as they are competitixe substrates
for NOS (Abe et al. 1995). It is difficult to assess firmly whether
there is a direct or indirect involvement ofNO in tumour cell cvto-
toxicity and its anticipated role in immunologDical anti-tumour
growth. This mav be important in our in vixo studies. as w e did not
test the effects of NO scaxengers and specific iNOS inhibitor.
Howexver. Awe haxe carried out different in xitro experiments to
address this problem.
In a first experiment on an original pancreatic tumour cell line
called HA-hpc,. SNP induced a dual tumour growth response: at
first a stimulatorx effect up to 0.5 n-Lt. followxed by an exponential
reduction ith increasing concentrations. Moreox er. the DNA
extracted from the tumour cells after SNP treatment x-as intact
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from 0.1 up to 0.5 rnmi. whereas at higher concentrations an inter-
nucleosomal fragmentation pattern. characteristic of apopotosis
induction. was present. These findings agree with the dual NO
tumoricidal action. depending on the local concentration of the
molecule suggested by Jenkins et al (1995). The proliferative
effect of NO. firmly established by its inhibition by the NO
scavenger carboxy-PTIO. could be explained by the well-known
involvement of cGMP in cell proliferation (Moncada et al. 1991).
The antiproliferative effect of NO is not related to breakdown
products of SNP such as cyanide or ferrocyanide as the NO scav-
enger carboxy-PTIO clearly inhibited both the drop in [ H]thymi-
dine incorporation and the tumour cell apoptosis induction. This
cytotoxicity may be related to the yield of iron nitrosyl complexes.
to the inhibition of mitochondrial respiration and DNA synthesis
(Stuehr and Nathan. 1989: Lepoivre et al. 1990). and to DNA
damage (Henle and Linn. 1997:Ibuky and Goto. 1997).
The pancreatic tumour cell line used (HA-hpc,) appeared unable
to produce NO after endotoxin and cytokine treatents. Under
the same experimental conditions. NO release from murine
macrophages showed almost a 15-fold increase. It seemslikely that
iNOSgene expression is very weak in this pancreatic tumour cell
line. Indeed the negative NOS assays were corroborated by the
undetectable iNOS mRNA expression after RT-PCR. However. this
result cannot be considered as true for all pancreatic cancers. A
disparity in iNOSgene expression has been demonstrated in colon
cancer cell lines (Jenkins et al. 1994). Moreover. the in vivo over-
expression of the iNOS gene in nonnal human airway epithelium
disappeared in primary culture (Guo et al. 1996).
In our data. the antiproliferative effect of cytokines on pancre-
atic tumour cell cultures reflected a more than 50% drop in
[H]thymidine incorporation in DNA. The anti-tumour effect we
have observed in vivo with L-arginine/LPS treatment may be
explained by the effect of cytokines released from endotoxin-acti-
vated immune cells. Thus. the tumoricidal effect of macrophages
was investigated on HA-hpc, as target cells. In co-cultures. the
influence of an increasing number ofmacrophages on NO biosyn-
thesis was tested in relation to pancreatic tumour cell antiprolifer-
ative effect. Pancreatic tumour cells were able to activate
macrophages without any stimulating factor. In the same way.
Thomas et al (1995) reported that the CC531 colon adenocarci-
noma cell line induced tumoricidal response of liver macrophages
in vivo. This effect. apparent 1 day after inoculation of tumour
cells in the liver. was still present after 4 weeks. As observed by
these authors the tumoricidal response disappeared with a ten
times higher tumour cell volume. Our results showing a tumori-
cidal efficiency dependent on macrophage density corroborate
these findings. The fact that an immune cell infiltration of a
tumour is not considered to be a good prognostic indicator of
tumour growth seems to contradict these data. We can draw the
hypothesis that these cells were not enough in number and/or are
not fully activated. Indeed, the treatment of Lewis rats after
pancreatic tumour allograft with LPS reduced drastically the
tumour size. Similarly macrophage activation via LPS addition in
co-culture fur-ther increased tumoricidal activity. as also observed
by Thomas et al (1995).
As this tumoricidal effect was not abrogated in the presence of
NOS inhibitor. Thomas et al (1995) suggested that the tumoricidal
response was not closely related to the production of reactive
nitrogen intermediates. Our observations agree only in part with
this hypothesis. If the NOS inhibitor used (L-NAME) significantly
reversed part of the antiproliferative effects of unstimulated and
stimulated macrophages. it was unable to abrogate the whole
antiproliferative effect. This failure could be due to both a low
specificity ofthis inhibitor and a relatively too high L-arginine
supplem,entation. responsible for an unfavourable substrate-
inhibitor competition. A non-NO-dependent macrophage cytotoxi-
city cannot be discarded. But NO biosynthesis and antiproliferative
effect were strongly correlated even after L-NAME addition.
Overall, the implication of the L-arginineNOS pathway in the
antiproliferative action of tumour-activated macrophages was
corroborated by the investigations on iNOS gene expression. In
macrophage-tumour cell co-cultures the enzyme activity of NOS
was drastically increased (30 times higher than in macrophages
alone), as was iNOS mRNA expression using RT-PCR assays.
We have also confirmed that the stimulation ofthe co-culture by
LPS/cytokines further activated macrophages. with an increased
NOS activity and a resulting increased NO biosynthesis respon-
sible for almost 70% further drop in ["H]thymidine incorporation.
These results suggest that the antiproliferative effect of
LPS/cytokines was linked to NO and nitrogen-reactive inter-
mediate generation. which may act on tumour cells in a paracrine
mode. This suggestion is in agreement with the report of an
increased endogenous nitrate synthesis in patients receiving
IL-2. demonstrating that a cytokine-inducible. high-output L-argi-
nine/NOS pathway exists in human beings (Hibbs et al. 1992).
The mechanism of macrophage activation by tumour cells is
still unclear. In our experiments. as well as those of Thomas et al
(1995). there was close contact between the two kinds of cells.
Using transwell cell co-culture systems will allow us to distinguish
between contact or contingent paracrine activating factors.
Moreover, it will be better to test this activating process on
syngenic cells since, as outlined by Adler et al (1996). iNOS regu-
lation in different species (human vs murine macrophages in our
experiments) differs considerably. with large changes in iNOS
gene expression in vitro (Jenkins et al. 1994: Adler et al. 1996:
Guoetal. 1996).
With an almost similar pattem ofNO generation. SNP produced
a dual proliferative and antiproliferative effect on tumour cells.
whereas activated macrophages induced a single antiproliferative
response. It is clear that SNP spontaneously produces NO. which
acts directly on tumour cells. In contrast. the cytotoxicity of
macrophages is multifactorial. involving at least both an enzy-
matic process capable of inducing the production of NO and a
release of numerous cytotoxic factors. In any case. NO seems to
play a key role in the pancreatic tumour cell toxicity observed in
our experiments. This cytotoxicity is probably linked to interac-
tions between NO and some reactive oxygen intermediates such as
superoxide anion. acting at several levels in the target cell
(Beckman et al. 1990: Nguyen et al. 1992: Henle and Linn. 1997:
Ibuki and Goto. 1977).
In conclusion, our expenrmental findings show that an antipro-
liferative effect was achieved on pancreatic adenocarcinoma both
in vivo and in vitro by the means of either exogenous or endoge-
nous NO generation. These NO-mediated cytostatic anti-tumour
effects seem to be macrophage/cell-mediated immunity dependent
and are increased by addition ofcytokines and endotoxins.
ABBREVIATIONS
Carboxy-PTIO. 2-phenyl-4.4.5.5-tetramethyl-hemidazoline- 1-
oxyl 3-oxide: GAPDH. glyceraldehyde-3-phosphate dehydroge-
nase: L-arg. L-Arginie: L-NAME. M-nitro-L-Arginine methyl
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ester. LPS. Iipopolysaccharide: NOS. nitric oxide synthase: SNP.
sodium nitroprusside.
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